ATM and cancer: Some studies have shown that cancer patients with ATM mutations have benefited from ICB therapy compared to those without ATM mutations [21–24], as ATM mutations were found to be correlated with TMB-H, increased expression of PD-L1 and ISGs [22, 25, 26].